United States

Analyst Research Report Snapshot


AB Science (AB) - Product Pipeline Review






19 Apr 2012





Companies referenced:


Available for Immediate Download

AB Science (AB) - Product Pipeline Review Summary AB Science (ABS) is a privtely held biopharmaceutical company. It is principally engaged in the research, development and commercialization of new targeted therapies called tyrosine kinase inhibitors. ABS is focused on developing therapeutics for both human and veterinary markets. The lead product candidate of ABS is Masitibib. This report is an insightful source for data, analysis and strategic insights into AB Science's drug pipeline and investigational products. The report also provides details on the drug description, mechanism of action, chemical details, therapeutic class and its development history. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope - Details of the company's products by development stage. - Pipeline products grouped by indication, therapy area, development stage and trial phase. - News updates on key events relating to the product and its development Reasons to Buy - A quick “one-stop-shop” to understand the company. - Identify competitor's pipeline products. - Take corrective measures on your own development programs and Research and Development initiatives based on regulatory events of competitor product pipelines. - Identify potential investment opportunities. - Timelines from concept to market lets you keep track of market potential build for a new product. - Assess a company's future growth by determining its drug pipeline depth, for probable acquisition opportunities

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.